YONGHE MEDICAL (02279) has released a positive profit forecast, projecting interim net earnings no lower than RMB25 million. This marks a significant financial reversal compared to the same period last year, transitioning from loss to profitability. The medical group's improved performance signals operational enhancements during the reporting period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments